Blog
Should You Buy the Dip on the 3 "Magnificent Seven" Stocks That Are Already Down in 2024?
"Magnificent Seven" is a term coined by Bank of America analyst Michael Hartnett to describe the seven largest tech-focused stocks in the S&P 500. They are Apple (NASDAQ: AAPL), Microsoft (NASDAQ:
Why Plug Power Stock Is Skyrocketing Today
Plug Power (NASDAQ: PLUG) stock is seeing explosive gains in Tuesday morning trading. The hydrogen-power company's share price was up by 19.7% as of 10:30 a.m. ET, according to data from S&P Global
General Electric (GE) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
General Electric (NYSE: GE)Q4 2023 Earnings CallJan 23, 2024, 7:30 a.m. ET
Operator
Source Fool.com
Is It Too Late to Buy DraftKings Stock?
There are two sides to every wager, and this was on display with DraftKings (NASDAQ: DKNG) late last week. Stifel upgraded the stock from hold to buy on Friday morning, just as BNP Paribas was
Why Fisker Stock Surged Again Today After an Explosive Monday
After an explosive Monday, Fisker (NYSE: FSR) stock rose even higher Tuesday morning, surging 10.8% within minutes of the market's opening. After announcing a new agreement with an institutional
Forget Amazon Stock, Buy This Magnificent E-Commerce Powerhouse Instead
E-commerce is one of the defining investment topics of the past few decades, and no company represents that more than Amazon, whose stock has returned a mind-melting 158,000% over its lifetime.
Why RTX Stock Jumped 8% Today
Shares of defense contracting giant RTX (NYSE: RTX) -- the artist formerly known as Raytheon -- jumped 8.2% through 10:30 a.m. ET after beating analyst forecasts for both sales and earnings Tuesday
Visa: Buy, Sell, or Hold?
In the last one-, three-, five-, and 10-year periods, Visa (NYSE: V) shares have beaten the gains of the S&P 500 (as of Jan. 18). This superb track record of consistent outperformance is only
Why 3M Stock Is Crashing Today
3M (NYSE: MMM) beat earnings expectations for 2023's fourth quarter, but management's outlook for 2024 was well below expectations. In response to the report from the manufacturing giant Tuesday
2 Reasons to Buy Teladoc Health Stock, and 1 Reason to Avoid It Like the Plague
Last year was a big one for most growth stocks, but Teladoc Health (NYSE: TDOC) didn't participate in the rally. Shares of America's largest telehealth provider dropped 9% in 2023 and are down 6% so
Here's Why Procter & Gamble Stock Jumped Today
Shares of consumer goods giant Procter & Gamble (NYSE: PG) jumped on Tuesday after the company reported financial results for its fiscal second quarter of 2024. As of 9:45 a.m. ET, P&G stock was up
Investing in Artificial Intelligence (AI) Stocks Can Be Risky, but Here's a Spectacular Way to Do It
Artificial intelligence (AI) was the dominant stock market theme in 2023. Nvidia experienced a surge in demand for its data center chips designed to process AI workloads, and its stock soared 239%
PayPal Stock Rises More Than 10% in a Week After New CEO Alex Chriss Promises That the Company Will "Shock the World"
In August, financial technology (fintech) pioneer PayPal Holdings (NASDAQ: PYPL) named Alex Chriss as its new president and CEO. Chriss officially took over on Sept. 27. Now four months later
3 Magnificent Artificial Intelligence (AI) Semiconductor Stocks to Buy in 2024
In this video, I will talk about three AI semiconductor companies that will greatly benefit from the AI revolution. These companies aren't talked about as much as Nvidia, AMD, or Intel, but they
Working and Claiming Social Security? There's Good News for 2024
Many seniors don't realize it, but the Social Security Administration can withhold money from your checks if you're still working while you claim benefits. Not all seniors run into this issue as
This EV Company Has a $10 Billion Secret Weapon
Like many high-growth stocks, Rivian Automotive has plummeted at the start of 2024. The electric vehicle (EV) maker's share price is down more than 30% to around its lowest level since November.
Everyone Is Talking About Medical Properties Trust. Is It a Good Long-Term Option?
Healthcare real estate investment trust Medical Properties Trust (NYSE: MPW) has been in the news a lot. The stock's dividend has been popular with investors, but it suffered a significant cut in
2 Passive Income Plays to Buy and Hold Forever
One of the best ways to enjoy retirement is to have a steady source of passive income. However, relying on Social Security payments alone likely won't give you a cushy post-work life.
After all, the
These 2 Growth Stocks Are Brilliant Buys for the New Year
While many economists predicted a recession in 2023, and macro volatility remains a factor that consumers and investors are still contending with, the grave headwinds many awaited with trepidation
Is Shopify Stock Too Expensive? Why It May Not Matter
Investors love Shopify (NYSE: SHOP) stock. The e-commerce platform's stock has more than doubled over the past year, and as inflation may be easing and e-commerce is growing, there's high investor
1 Setback and 1 Opportunity for CRISPR Therapeutics Stock
With CRISPR Therapeutics (NASDAQ: CRSP) in the news thanks to its successful work in developing cutting-edge gene therapies, it's easy to assume that everything in the business is going swimmingly
Ranking 6 Popular Stocks From Best to Worst
In today's video, I rank six popular stocks from highest quality to lowest. One of those must-own companies is Nvidia Corp (NASDAQ: NVDA).
Check out this short video to learn more, consider
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Novavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability to bring a coronavirus vaccine to market. The company followed through on that -- but not as
How Should a Beginner Invest in Stocks? Start With This ETF.
Investing in the stock market can be one of the best financial decisions you make as the long-term returns can be life-changing for individuals looking to achieve their retirement goals.
While
This 1 Bullish Move by Merck Could Drive Growth for Years to Come
On Jan. 8, pharmaceutical giant Merck (NYSE: MRK) moved to acquire biotech Harpoon Therapeutics, (NASDAQ: HARP) for $680 million in cash. The point of the acquisition, which should close in the


